INDV 241220 20.00P (INDV241220P20000) Stock Options, News & Quotes

Account Info

Log Out

US OptionsDetailed Quotes

INDV241220P20000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 22 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Indivior to Engage With Investors at Healthcare Conference
TipRanksNov 22 02:07 ET
Indivior Shares Sublocade Trial Findings at CSAM Conference
TipRanksNov 19 13:00 ET
Indivior Data Shows Rapid Initiation With Once-Monthly SUBLOCADE Significantly Improves Retention In Opioid Use Disorder Patients, Especially Among Fentanyl-Positive Participants; Study Also Administered Second SUBLOCADE Injection A Week Later Vs....
BenzingaNov 19 12:55 ET
Indivior PLC Executes Strategic Share Repurchase
TipRanksNov 19 09:59 ET
Indivior's Voting Rights Shift With Madison Avenue
TipRanksNov 18 09:28 ET
US Manufacturing Index Rises To 43, Highest Since 2020
Business TodayNov 16 02:13 ET

Comments

Jaguar8

Oct 10 06:07

NEWS

$Indivior (INDV.US)$
Indivior Provides Preliminary Q3 2024 Results; Updates FY 2024 Guidance; Group Continues to Expect SUBLOCADE Peak Net Revenue of >$1.5 Billion
RICHMOND, Va., Oct. 10, 2024 /PRNewswire/ -- Indivior PLC (Nasdaq/LSE: INDV) today announced preliminary Q3 2024 financial results and provided updated FY 2024 guidance.
• Group now sees lower than expected Q3 2024 and FY 2024 SUBLOCADE net revenue (NR) from a combination of faster initial adoption among treatment providers of the...

Moomoo AI

Feb 22 08:25

Indivior's potential U.S. market move reflects its growth opportunities and is expected to attract more U.S. investors. Strong financial performance and positive revenue outlook may also boost investor interest.

Indivior Shares Jump on Possible U.S. Listing, Swing to Pretax Profit